Phospholamban (PLN) (pSer16), (pSer17) Peptide
PLN
Reactivité: Humain, Rat, Boeuf (Vache), Chien, Souris, Porc, Lapin
Hôte: Synthetic
BP
(1 reference)
N° du produit ABIN2711843
Aperçu rapide pour Phospholamban (PLN) (pSer16), (pSer17) Peptide (ABIN2711843)
Antigène
Phospholamban (PLN)
Origine
Humain, Rat, Boeuf (Vache), Chien, Souris, Porc, Lapin
Source
Synthetic
Application
Blocking Peptide (BP)
-
-
Protein Region
- pSer16, pSer17
-
Attributs du produit
- The peptide is used to block Anti-Phospholamban (pS16/T17) Antibody reactivity.
-
-
-
-
Indications d'application
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Stock
- -20 °C
-
Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year.
-
Date de péremption
- 12 months
-
-
-
: "Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening"." dans: PloS one, Vol. 16, Issue 4, pp. e0250319, (2021) (PubMed).
-
: "Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening"." dans: PloS one, Vol. 16, Issue 4, pp. e0250319, (2021) (PubMed).
-
-
Vous êtes ici:
